The data published in NEJM highlight the positive Phase 3 VALIANT results at Week 26, which were consistent across adolescent and adult patients with C3G and primary IC-MPGN, including patients with ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that the latest findings on time savings with continued treatment with humanized anti-soluble ...

Researchers are urging collaborators to think about the best structural resolution for their formulation models.

Several 3D printing technologies are currently considered more clinically applicable, including SSE, fused deposition ...

Following the success of training programmes of public drug testing labs in 10 states in the country, the Indian Pharmacopoeia Commission (IPC) is all set to launch pan-India capacity building ...

The Drugs Consultative Committee (DCC), the advisory committee that advises the Central and State Governments on matters that require uniform implementation of drug laws across the country, has ...

India’s drug regulator has sounded a fresh alarm over toxic solvent contamination in paediatric syrups, prompting urgent ...

Drug safety relates to the potential for adverse effects related to the administration of drugs. Efforts to establish the safely profile of drugs begin early in their development, with in vitro and in ...

A high-throughput screen that measures bacterial metabolism and host cell viability identified a host-directed compound (KL1) that reactivates intracellular bacteria that have developed antibiotic ...

Sudeep Pharma is set to list today after raising Rs 895 crore through a mix of fresh shares and an offer for sale. The grey ...

The newly secured funding will accelerate the build-out and launch of Rena’s Texas facility, which is expected to become ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...